Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CFO Vikram Verghese sold 3,587 shares of the stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $53.15, for a total transaction of $190,649.05. Following the sale, the chief financial officer directly owned 149,587 shares in the company, valued at approximately $7,950,549.05. This represents a 2.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Vikram Verghese also recently made the following trade(s):
- On Friday, September 18th, Vikram Verghese sold 16,766 shares of Heartflow stock. The stock was sold at an average price of $50.75, for a total transaction of $850,874.50.
- On Thursday, September 17th, Vikram Verghese sold 7,579 shares of Heartflow stock. The stock was sold at an average price of $50.11, for a total transaction of $379,783.69.
- On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The shares were sold at an average price of $50.01, for a total transaction of $33,406.68.
- On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The shares were sold at an average price of $50.24, for a total transaction of $230,752.32.
- On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total transaction of $1,487,482.84.
- On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total transaction of $332,199.20.
- On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total value of $1,368,462.60.
- On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total value of $297,325.60.
Heartflow Trading Up 5.9%
Shares of HTFL opened at $59.10 on Thursday. The business’s fifty day moving average price is $51.73 and its two-hundred day moving average price is $35.00. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $60.66.
Heartflow (NASDAQ:HTFL – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The company had revenue of $64.08 million during the quarter. The business’s quarterly revenue was up 47.7% compared to the same quarter last year. Research analysts anticipate that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the company. UBS Group started coverage on Heartflow in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price objective for the company. Wall Street Zen downgraded shares of Heartflow from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Stifel Nicolaus lifted their price target on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. Finally, Wells Fargo & Company boosted their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $48.62.
Read Our Latest Report on HTFL
Institutional Trading of Heartflow
A number of institutional investors and hedge funds have recently modified their holdings of the stock. XXEC Inc. bought a new position in Heartflow during the 2nd quarter worth approximately $2,524,764,000. BlackRock Inc. bought a new stake in Heartflow in the second quarter valued at approximately $152,502,000. Bamco Inc. NY acquired a new stake in Heartflow in the second quarter worth $94,625,000. Jupiter Topco LLC acquired a new stake in Heartflow in the second quarter worth $70,983,000. Finally, Janus Henderson Group PLC boosted its position in shares of Heartflow by 152.0% during the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after purchasing an additional 1,315,416 shares in the last quarter.
Heartflow Company Profile
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Featured Articles
- Five stocks we like better than Heartflow
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
